Article

Websdale, Alex, Kiew, Yi, Chalmers, Philip, Chen, Xinyu, Cioccoloni, Giorgia, Hughes, Thomas A. ORCID: https://orcid.org/0000-0003-1169-3386, Luo, Xinyu, Mwarzi, Rufaro, Poirot, Marc, Røberg-Larsen, Hanne, Wu, Ruoying, Xu, Mengfan, Zulyniak, Michael A. and Thorne, James L. (2022) Pharmacologic and genetic inhibition of cholesterol esterification enzymes reduces tumour burden: a systematic review and meta-analysis of preclinical models. Biochemical pharmacology, 196 (11473).

Baxter, Diana E., Allinson, Lisa M., Al Amri, Waleed S., Poulter, James A., Pramanik, Arindam, Thorne, James L., Verghese, Eldo T. and Hughes, Thomas A ORCID: https://orcid.org/0000-0003-1169-3386 (2021) MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast Cancer. Cancers, 13 (23). p. 5979.

Gwili, Noha, Jones, Stacey J., Al Amri, Waleed, Carr, Ian M., Harris, Sarah, Hogan, Brian V., Hughes, William E., Kim, Baek, Langlands, Fiona E., Millican-Slater, Rebecca A., Pramanik, Arindam, Thorne, James L., Verghese, Eldo T., Wells, Geoff, Hamza, Mervat, Younis, Layla, El Deeb, Nevine M. F. and Hughes, Thomas A ORCID: https://orcid.org/0000-0003-1169-3386 (2021) Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response. British journal of cancer, 125. pp. 983-993.

Hutchinson, Samantha A., Websdale, Alex, Cioccoloni, Giorgia, Røberg-Larsen, Hanne, Lianto, Priscilia, Kim, Baek, Rose, Ailsa, Soteriou, Chrysa, Pramanik, Arindam, Wastall, Laura M., Williams, Bethany J., Henn,, Madeline A., Chen, Joy J., Ma, Liqian, Moore, J. Bernadette, Nelson, Erik, Hughes, Thomas A ORCID: https://orcid.org/0000-0003-1169-3386 and Thorne, James L. (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883.

Broad, Robyn V., Jones, Stacey J., Teske, Melina C., Wastall, Laura M., Hanby, Andrew M., Thorne, James L. and Hughes, Thomas A ORCID: https://orcid.org/0000-0003-1169-3386 (2021) Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy. British Journal of Cancer, 124. pp. 1110-1120.